Bi R - Search Results

1

Prognostic value of programmed death-ligand 1 (PD-L1) expression in ovarian clear cell carcinoma.

Zhu J, Wen H, Bi R, Wu Y, Wu X. Zhu J, et al. Among authors: bi r. J Gynecol Oncol. 2017 Nov;28(6):e77. doi: 10.3802/jgo.2017.28.e77. J Gynecol Oncol. 2017. PMID: 29027395 Free PMC article.

2

Thrombocytosis and hyperfibrinogenemia are predictive factors of clinical outcomes in high-grade serous ovarian cancer patients.

Feng Z, Wen H, Bi R, Duan Y, Yang W, Wu X. Feng Z, et al. Among authors: bi r. BMC Cancer. 2016 Jan 27;16:43. doi: 10.1186/s12885-016-2070-2. BMC Cancer. 2016. PMID: 26817451 Free PMC article.

3

Clear cell carcinomas of the ovary: a mono-institutional study of 73 cases in China with an analysis of the prognostic significance of clinicopathological parameters and IMP3 expression.

Bi R, Shen X, Zhang W, Cheng Y, Feng Z, Cai X, Yang W. Bi R, et al. Diagn Pathol. 2016 Feb 2;11:17. doi: 10.1186/s13000-016-0467-5. Diagn Pathol. 2016. PMID: 26837693 Free PMC article.

4

Prognostic impact of the time interval from primary surgery to intravenous chemotherapy in high grade serous ovarian cancer.

Feng Z, Wen H, Bi R, Yang W, Wu X. Feng Z, et al. Among authors: bi r. Gynecol Oncol. 2016 Jun;141(3):466-470. doi: 10.1016/j.ygyno.2016.04.016. Epub 2016 Apr 23. Gynecol Oncol. 2016. PMID: 27098361

5

A clinically applicable molecular classification for high-grade serous ovarian cancer based on hormone receptor expression.

Feng Z, Wen H, Bi R, Ju X, Chen X, Yang W, Wu X. Feng Z, et al. Among authors: bi r. Sci Rep. 2016 May 3;6:25408. doi: 10.1038/srep25408. Sci Rep. 2016. PMID: 27139372 Free PMC article.

6

Preoperative Neutrophil-to-Lymphocyte Ratio as a Predictive and Prognostic Factor for High-Grade Serous Ovarian Cancer.

Feng Z, Wen H, Bi R, Ju X, Chen X, Yang W, Wu X. Feng Z, et al. Among authors: bi r. PLoS One. 2016 May 20;11(5):e0156101. doi: 10.1371/journal.pone.0156101. eCollection 2016. PLoS One. 2016. PMID: 27203425 Free PMC article.

7

Expression of hypothalamic-pituitary-gonadal axis-related hormone receptors in low-grade serous ovarian cancer (LGSC).

Feng Z, Wen H, Ju X, Bi R, Chen X, Yang W, Wu X. Feng Z, et al. Among authors: bi r. J Ovarian Res. 2017 Jan 25;10(1):7. doi: 10.1186/s13048-016-0300-5. J Ovarian Res. 2017. PMID: 28122595 Free PMC article.

8

Clinical Significance of Programmed Death Ligand‑1 and Intra-Tumoral CD8+ T Lymphocytes in Ovarian Carcinosarcoma.

Zhu J, Wen H, Ju X, Bi R, Zuo W, Wu X. Zhu J, et al. Among authors: bi r. PLoS One. 2017 Jan 26;12(1):e0170879. doi: 10.1371/journal.pone.0170879. eCollection 2017. PLoS One. 2017. PMID: 28125702 Free PMC article.

9

Characterization of ovarian clear cell carcinoma using target drug-based molecular biomarkers: implications for personalized cancer therapy.

Li M, Li H, Liu F, Bi R, Tu X, Chen L, Ye S, Cheng X. Li M, et al. Among authors: bi r. J Ovarian Res. 2017 Feb 10;10(1):9. doi: 10.1186/s13048-017-0304-9. J Ovarian Res. 2017. PMID: 28187748 Free PMC article.

10

Hormone receptor expression profiles differ between primary and recurrent high-grade serous ovarian cancers.

Feng Z, Wen H, Ju X, Bi R, Chen X, Yang W, Wu X. Feng Z, et al. Among authors: bi r. Oncotarget. 2017 May 16;8(20):32848-32855. doi: 10.18632/oncotarget.15858. Oncotarget. 2017. PMID: 28416763 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

940 results

Search Page

Filters